Kimberly K. Leslie

Also affiliated with New Mexico Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.1Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Genomic characterization of five commonly used endometrial cancer cell lines

International Journal of Oncology(2020)10.3892/ijo.2020.5139

Top 18%

1.1DataRank

Top 18%43 citations

Jesús González Bosquet, Kristina W. Thiel, Kimberly K. Leslie, Eric J. Devor

Papers

Driven by 28 papers — median percentile 82. Top paper: “Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study”.

Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.01.025

N/A

2.5DataRank · unranked

85 citations

Virginia L. Filiaci, Adrianne Mallen, Kristina W. Thiel, Eric J. Devor, Katherine Moxley +17 more

Genomic characterization of five commonly used endometrial cancer cell lines

International Journal of Oncology(2020)10.3892/ijo.2020.5139

Top 18%

1.1DataRank

Top 18%43 citations

Jesús González Bosquet, Kristina W. Thiel, Kimberly K. Leslie, Eric J. Devor

Creation and validation of models to predict response to primary treatment in serous ovarian cancer

Scientific Reports(2021)10.1038/s41598-021-85256-9

N/A

0.515DataRank · unranked

30 citations

Eric J. Devor, A.M. Newtson, Brian J. Smith, David Bender, Michael J. Goodheart +5 more

Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer

Cell Death and Disease(2022)10.1038/s41419-022-04508-2

N/A

0.494DataRank · unranked

26 citations

Yuping Zhang, Paige K. Malmrose, Haley A. Losh, A.M. Newtson, Eric J. Devor +3 more

FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways

Clinical and Translational Medicine(2023)10.1002/ctm2.1223

N/A

0.477DataRank · unranked

23 citations

Jesús González Bosquet, Joseph Skurski, Eric J. Devor, Erin B. Dickerson, Warren B. Nothnick +4 more

A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4618

N/A

0.464DataRank · unranked

21 citations

Virginia L. Filiaci, Joan L. Walker, Laura L. Holman, Emily K. Hill, Richard G. Moore +13 more

Bacterial, Archaea, and Viral Transcripts (BAVT) Expression in Gynecological Cancers and Correlation with Regulatory Regions of the Genome

Cancers(2021)10.3390/cancers13051109

N/A

0.425DataRank · unranked

16 citations

Silvana Pedra-Nobre, Eric J. Devor, Kristina W. Thiel, Michael J. Goodheart, David Bender +2 more

The Synthetic Curcumin Analog HO-3867 Rescues Suppression of PLAC1 Expression in Ovarian Cancer Cells

Pharmaceuticals(2021)10.3390/ph14090942

N/A

0.345DataRank · unranked

9 citations

Brandon Schickling, Jace R. Lapierre, David Bender, Jesús González Bosquet, Kimberly K. Leslie +1 more

Global expression analysis of endometrial cancer cells in response to progesterone identifies new therapeutic targets

The Journal of Steroid Biochemistry and Molecular Biology(2023)10.1016/j.jsbmb.2023.106399

N/A

0.165DataRank · unranked

2 citations

A.M. Newtson, Eric J. Devor, Yuping Zhang, Paige K. Malmrose, Jianling Bi +13 more

Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High Grade Serous Ovarian Cancer

Research Square(2022)10.21203/rs.3.rs-1167716/v1

N/A

0DataRank · unranked

3 citations

Eric J. Devor, Silvana Pedra Nobre, A.M. Newtson, Kimberly K. Leslie, David Bender +4 more

Characterization of a novel estrogen- and progesterone-responsive endometrial cancer cell line: HCI-EC-23

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.25.505203

N/A

0DataRank · unranked

0 citations

Zannel Blanchard, Jacob T. Polaski, Kyle S. Osborne, Krystle Osby, Jeffery M. Vahrenkamp +8 more

Particles and Prejudice: Nanomedicine Approaches to Reducing Health Disparities in Endometrial Cancer

Small(2023)10.1002/smll.202300096

N/A

0DataRank · unranked

9 citations

Abigail M. Folberg, Zachary K. Beickman, Eric J. Devor, Kimberly K. Leslie, Brittany E. Givens +1 more

Microbial Communities in Gynecological Cancers and Their Association with Tumor Somatic Variation

Cancers(2023)10.3390/cancers15133316

N/A

0DataRank · unranked

3 citations

Megan McDonald, David Bender, Bruce A. Smith, Kimberly K. Leslie, Michael J. Goodheart +2 more

Multiplexed live-cell imaging for drug responses in patient-derived organoid models of cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.15.567243

N/A

0DataRank · unranked

2 citations

Emily L. Symons, Lorenzo Buroni, Hiruni K. Sumanisiri, Jessica Andrew-Udoh, Emily Witt +7 more

Multiplexed Live-Cell Imaging for Drug Responses in Patient-Derived Organoid Models of Cancer

Journal of Visualized Experiments(2024)10.3791/66072

N/A

0DataRank · unranked

4 citations

Emily L. Symons, Lorenzo Buroni, Hiruni K. Sumanasiri, Jessica Andrew-Udoh, Emily Witt +7 more

Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer

Cancers(2025)10.3390/cancers17040598

N/A

0DataRank · unranked

14 citations

Ian S. Hagemann, David G. Mutch, Eric J. Devor, Paige K. Malmrose, Yuping Zhang +4 more

Novel p53 reactivators that are synergistic with olaparib for the treatment of gynecologic cancers with mutant p53

Translational Oncology(2025)10.1016/j.tranon.2025.102522

N/A

0DataRank · unranked

6 citations

Jamie L. Padilla, Angelina Licor, Mara P. Steinkamp, Irina V. Lagutina, Yan Guo +8 more

The STEAP4 target NQO1 mediates colon tumorigenesis

Journal of Cell Science(2025)10.1242/jcs.263402

N/A

0DataRank · unranked

4 citations

Luke Villareal, Xiangxiang Wu, Mariella Arcos, Jordan Lee, David Martin +5 more

The novel curcumin analogue AKT-100 targets both mutant p53 and STAT3 in gynecologic cancer cells

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.06.680794

N/A

0DataRank · unranked

1 citations

Lane E. Smith, Jamie L. Padilla, Alexander Goss, Daisy Belmares-Ortega, Xiangxiang Wu +7 more

The potential for p53 reactivators to increase the sensitivity of aggressive gynecologic cancers to immunotherapy 3272

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1090

N/A

0DataRank · unranked

0 citations

Jamie L. Padilla, Geneva L. Williams, Daisy Belmares-Ortega, Xiangxiang Wu, Eric Bartee +2 more

Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.12.007

N/A

0DataRank · unranked

40 citations

Kathryn P. Pennington, Barbara M. Norquist, Nithisha Khasnavis, Marc R. Radke, Mark Kilgore +7 more

ES-2 Ovarian Cancer Cells Present a Genomic Profile Inconsistent with their Reported History

Research Square(2020)10.21203/rs.3.rs-28022/v1

N/A

0DataRank · unranked

1 citations

Jace R. Lapierre, Kimberly K. Leslie, David Bender, Eric J. Devor

Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing

Cancers(2021)10.3390/cancers13122901

N/A

0DataRank · unranked

68 citations

A.M. Newtson, Yuping Zhang, Eric J. Devor, Megan I. Samuelson, Kristina W. Thiel +2 more

Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy

Pharmaceuticals(2021)10.3390/ph14070682

N/A

0DataRank · unranked

15 citations

Garima Dixit, Yuping Zhang, Eric J. Devor, Haley A. Losh, A.M. Newtson +6 more

Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib Over Bevacizumab: Cell Cycle Abrogation and Synergy With Chemotherapy

Research Square(2021)10.21203/rs.3.rs-179830/v1

N/A

0DataRank · unranked

1 citations

Garima Dixit, Yuping Zhang, Eric J. Devor, Haley A. Losh, A.M. Newtson +6 more

Utilizing an Endogenous Progesterone Receptor Reporter Gene for Drug Screening and Mechanistic Study in Endometrial Cancer

Cancers(2022)10.3390/cancers14194883

N/A

0DataRank · unranked

6 citations

Wei Zhou, Xiangbing Meng, S. Murray, Long Li, Abby Fronk +7 more

Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer

Cancers(2022)10.3390/cancers14143554

N/A

0DataRank · unranked

5 citations

Eric J. Devor, Silvana Pedra Nobre, A.M. Newtson, Kimberly K. Leslie, David Bender +4 more

Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line

Scientific Reports(2022)10.1038/s41598-022-24211-8

N/A

0DataRank · unranked

4 citations

Zannel Blanchard, Jacob T. Polaski, Kyle S. Osborne, Krystle Osby, Jeffery M. Vahrenkamp +8 more

Kimberly K. Leslie

Indexed papers

Top data-sharing exemplar

Papers